Immunocore Adds GlaxoSmithKline To Its Growing List Of Partners
This article was originally published in The Pink Sheet Daily
Executive Summary
The British biotech has found validation in two recent partnerships for its cancer immunotherapy platform, while gaining the resources to continue developing its lead compound on its own.